Medroxyprogesterone Acetate Patent Expiration
Medroxyprogesterone Acetate was first introduced by Pfizer Inc
Medroxyprogesterone Acetate Patents
Given below is the list of patents protecting Medroxyprogesterone Acetate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Depo-subq Provera 104 | US6495534 | Stabilized aqueous suspensions for parenteral use |
May 15, 2020
(Expired) | Pfizer |
Try Our Curated Drug Screens
Medroxyprogesterone Acetate Generics
Several generic applications have been filed for Medroxyprogesterone Acetate. The first generic version for Medroxyprogesterone Acetate was by Solvay Pharmaceuticals and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Amneal Eu Ltd and was approved on Jun 7, 2023.
Given below is the list of companies who have filed for Medroxyprogesterone Acetate generic.
1. AMARIN PHARMS
Amarin Pharmaceuticals Inc has filed for 1 generic for Medroxyprogesterone Acetate. This 10mg version comes by the name AMEN. Given below are the details of the strengths of this generic introduced by Amarin Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
2. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Amneal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Prescription | INJECTION | AB | Jun 7, 2023 |
3. AMPHASTAR PHARMS INC
Amphastar Pharmaceuticals Inc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Amphastar Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Prescription | INJECTION | AB | Nov 28, 2017 |
4. BARR
Barr Laboratories Inc has filed for 3 different strengths of generic version for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Barr.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG | tablet | Prescription | ORAL | AB | Aug 9, 1996 |
10MG | tablet | Prescription | ORAL | AB | Aug 9, 1996 |
5MG | tablet | Prescription | ORAL | AB | Aug 9, 1996 |
5. CIPLA
Cipla Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Cipla.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Discontinued | INJECTION | N/A | Jan 25, 2019 |
6. DURAMED PHARMS BARR
Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc has filed for 3 different strengths of generic version for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Duramed Pharms Barr.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Dec 1, 1999 |
5MG | tablet | Discontinued | ORAL | N/A | Dec 1, 1999 |
2.5MG | tablet | Discontinued | ORAL | N/A | Dec 1, 1999 |
7. ESI
Esi Pharmacal has filed for 3 different strengths of generic version for Medroxyprogesterone Acetate. All of these versions come by the name CYCRIN. Given below are the details of the strengths of this generic introduced by Esi.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Sep 9, 1987 |
5MG | tablet | Discontinued | ORAL | N/A | Oct 30, 1992 |
2.5MG | tablet | Discontinued | ORAL | N/A | Oct 30, 1992 |
8. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Prescription | INJECTION | AB | Aug 31, 2022 |
9. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Discontinued | INJECTION | N/A | Jan 5, 2023 |
10. HONG KONG
Hong Kong King Friend Industrial Co Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Hong Kong.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Prescription | INJECTION | AB | Jul 28, 2004 |
11. SANDOZ
Sandoz Inc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Discontinued | INJECTION | N/A | May 20, 2009 |
12. SOLVAY
Solvay Pharmaceuticals has filed for 1 generic for Medroxyprogesterone Acetate. This 10mg version comes by the name CURRETAB. Given below are the details of the strengths of this generic introduced by Solvay.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
13. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Discontinued | INJECTION | N/A | May 1, 2019 |
14. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Discontinued | INJECTION | N/A | Oct 27, 2004 |
15. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Jul 26, 1984 |
16. XIROMED
Xiromed Llc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Xiromed.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG/ML | injectable | Prescription | INJECTION | AB | Oct 12, 2018 |